Researcher
Sare Verstockt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2019 → Today - Laboratory for Complex Genetics (Division)
Member
From1 Oct 2015 → 30 Sep 2019
Projects
1 - 3 of 3
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Lipidomic, microbial and functional characterization of triggers of post-operative recurrence in Crohn’s diseaseFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Molecular profiling of early events in the pathogenesis of inflammatory bowel diseaseFrom1 Oct 2015 → 9 Oct 2019Funding: BOF - doctoral mandates, BOF - Doctoral projects
Publications
11 - 20 of 44
- Extracellular Vesicles in Inflammatory Bowel Disease: Small Particles, Big Players(2021)
Authors: Sare Verstockt, Isabelle Cleynen
Pages: 499 - 510 - Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease(2021)
Authors: Sare Verstockt, Bram Verstockt, Kathleen Machiels, Marc Ferrante, Isabelle Cleynen, Gert De Hertogh, Séverine Vermeire
Pages: 1564 - 1575 - Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation(2020)
Authors: Michelle Stakenborg, Bram Verstockt, Veronica De Simone, Sare Verstockt, Mario di Matteo, Marc Ferrante, Guy Boeckxstaens, Séverine Vermeire, Gianluca Matteoli
Pages: 1748 - 1758 - Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis(2020)
Authors: Sare Verstockt, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
- Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases(2020)
Authors: Bram Verstockt, Sare Verstockt, Jonas Dehairs, Kaline Arnauts, Gert Van Assche, Gert De Hertogh, Séverine Vermeire, Marc Ferrante
Pages: 1142 - + - MACHINE LEARNING APPROACHES VALIDATE SEROLOGICAL MARKERS FOR EARLY AND DIFFERENTIAL DIAGNOSIS(2020)
Authors: Sare Verstockt, Nora Verplaetse, Daniele Raimondi, Bram Verstockt, Yves Moreau, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Pages: S687 - S687 - DEVELOPMENT OF AN EASY AND RAPID GENOTYPING ASSAY FOR THE VALIDATED IBD RISK LOCI(2020)
Authors: Sare Verstockt, Bram Verstockt, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Pages: S793 - S794 - A MUCOSAL MARKER PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS(2020)
Authors: Bram Verstockt, Sare Verstockt, Dahham Alsoud, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire
Pages: S688 - S689 - Serum protein markers for early and differential IBD diagnosis validated by machine learning approaches(2020)
Authors: Sare Verstockt, Nora Verplaetse, Daniele Raimondi, Bram Verstockt, Yves Moreau, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Pages: S070 - S070 - Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)(2019)
Authors: Sare Verstockt, Bram Verstockt, Séverine Vermeire
Pages: 943 - 954